Security key
52886X107
Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO)
CUSIP: 52886X107
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 74,507,639
- Total 13F shares
- 49,322,779
- Share change
- +7,097,310
- Total reported value
- $327,479,655
- Price per share
- $6.64
- Number of holders
- 108
- Value change
- +$52,645,662
- Number of buys
- 75
- Number of sells
- 21
Report period
Q3 2025
Institutions
108
Top holders
10
LXEO full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Lexeo Therapeutics, Inc. SEC filings
Lexeo Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52886X107
Recent filing periods:
Top shareholders of LXEO - Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vestal Point Capital, LP |
13D/G
13F
|
Company |
7.5%
|
4,117,302
|
$27,338,885 | +$5,903,896 | 30 Sep 2025 | |
| MIZUHO FINANCIAL GROUP INC |
13D/G
|
— |
6.6%
|
2,203,631
|
$8,109,362 | +$1,020,464 | 31 Mar 2025 | |
| Longitude Capital Partners IV, LLC |
3/4/5
13D/G
|
10%+ Owner |
3.8%
from 13D/G
|
2,567,100
|
$33,933,468 | — | 07 Nov 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13D/G
|
— |
3.7%
|
1,234,834
|
$4,544,189 | $0 | 31 Dec 2024 | |
| Omega Fund VI, L.P. |
3/4/5
13D/G
|
10%+ Owner |
3.6%
from 13D/G
|
2,157,623
|
$28,520,755 | — | 07 Nov 2023 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
3.2%
|
2,313,642
|
$15,362,583 | -$3,470,396 | 30 Sep 2025 | |
| D1 Capital Partners L.P. |
13F
13D/G
|
Company |
2.9%
from 13D/G
|
978,652
|
$3,934,181 | — | 30 Jun 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
0.7%
|
237,953
|
$875,667 | -$7,255,716 | 31 Mar 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
5.9%
|
4,424,725
|
$17,787,395 | — | 30 Jun 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
5.4%
|
4,009,137
|
$16,116,731 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.9%
|
3,684,383
|
$14,834,628 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
4.8%
|
3,607,967
|
$14,504,027 | — | 30 Jun 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
4.8%
|
3,589,355
|
$14,429,207 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.8%
|
2,836,292
|
$11,401,894 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
3.5%
|
2,572,162
|
$10,340,091 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
2,002,866
|
$8,051,521 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2.5%
|
1,827,964
|
$7,348,416 | — | 30 Jun 2025 | |
| Omega Fund Management, LLC |
13F
|
Company |
1.6%
|
1,184,636
|
$4,762,237 | — | 30 Jun 2025 | |
| Blackstone Inc. |
13F
|
Company |
1.5%
|
1,124,922
|
$4,522,186 | — | 30 Jun 2025 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
1.2%
|
867,302
|
$3,486,554 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.87%
|
647,880
|
$2,604,478 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.81%
|
603,435
|
$2,425,809 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.78%
|
578,081
|
$2,324,528 | — | 30 Jun 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.74%
|
550,029
|
$2,211,117 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.69%
|
513,026
|
$2,062,365 | — | 30 Jun 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.56%
|
414,863
|
$1,667,749 | — | 30 Jun 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.51%
|
378,083
|
$1,519,894 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
271,904
|
$1,093,054 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.27%
|
200,786
|
$807,159 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.25%
|
188,635
|
$758,314 | — | 30 Jun 2025 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.24%
|
178,356
|
$752,662 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
163,172
|
$655,951 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.19%
|
145,109
|
$583,338 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.19%
|
139,835
|
$562,137 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.16%
|
116,142
|
$466,891 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
106,200
|
$426,924 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
84,781
|
$340,820 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
69,242
|
$278,353 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
65,152
|
$261,911 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.09%
|
64,220
|
$258,164 | — | 30 Jun 2025 | |
| Palumbo Wealth Management LLC |
13F
|
Company |
0.08%
|
56,303
|
$226,339 | — | 30 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
53,400
|
$214,668 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.07%
|
48,434
|
$194,705 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
48,011
|
$193,004 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.06%
|
47,023
|
$189,032 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
36,368
|
$146,200 | — | 30 Jun 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
34,741
|
$139,659 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.04%
|
33,102
|
$133,070 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
31,990
|
$128,591 | — | 30 Jun 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.04%
|
29,779
|
$120,307 | — | 30 Jun 2025 |
Institutional Holders of Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO) as of Q3 2025
As of 30 Sep 2025,
Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,322,779 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Frazier Life Sciences Management, L.P., Balyasny Asset Management L.P., Affinity Asset Advisors, LLC, CITADEL ADVISORS LLC, Vestal Point Capital, LP, Woodline Partners LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, and BlackRock, Inc..
This page lists
109
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
90
Q3 2025 holders
108
Holder diff
18
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.